EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iron status influences mitochondrial disease progression in Complex I-deficient mice

C J Kelly, Reid K Couch, Vivian T Ha, Camille M Bodart, Judy Wu, Sydney Huff, Nicole T Herrel, Hyunsung D Kim, Azaad O Zimmermann, Jessica Shattuck, Yu-Chen Pan, Matt Kaeberlein iD und 1 weitere

eLife · 2023

DOI: 10.7554/elife.75825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2023. Verfasst von C J Kelly und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine & Pathology, University of Washington, Seattle, United States. Hauptthemen laut MEDLINE: Leigh Disease, Mitochondrial Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction caused by aberrant Complex I assembly and reduced activity of the electron transport chain is pathogenic in many genetic and age-related diseases. Mice missing the Complex I subunit NADH dehydrogenase [ubiquinone] iron-sulfur protein 4 (NDUFS4) are a leading mammalian model of severe mitochondrial disease that exhibit many characteristic symptoms of Leigh Syndrome including oxidative stress, neuroinflammation, brain lesions, and premature death. NDUFS4 knockout mice have decreased expression of nearly every Complex I subunit. As Complex I normally contains at least 8 iron-sulfur clusters and more than 25 iron atoms, we asked whether a deficiency of Complex I may lead to iron perturbations, thereby accelerating disease progression. Consistent with this, iron supplementation accelerates symptoms of brain degeneration in these mice, while iron restriction delays the onset of these symptoms, reduces neuroinflammation, and increases survival. NDUFS4 knockout mice display signs of iron overload in the liver including increased expression of hepcidin and show changes in iron-responsive element-regulated proteins consistent with increased cellular iron that were prevented by iron restriction. These results suggest that perturbed iron homeostasis may contribute to pathology in Leigh Syndrome and possibly other mitochondrial disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leigh DiseaseMitochondrial DiseasesMiceAnimalsIronNeuroinflammatory DiseasesMitochondriaElectron Transport Complex IMice, KnockoutMammals

Stichwörter der Autor:innen

biochemistrychemical biologyelectron transport chainiron overloadiron restrictionleigh syndromemedicinemitochondrial diseasemouseneurometabolic

Substanzen

IronElectron Transport Complex INdufs4 protein, mouse

Autor:innen und Institutionen

  • Department of Laboratory Medicine & Pathology, University of Washington, Seattle, United States.

ORCID-Profile: Matt Kaeberlein, Anthony S Grillo

Förderung

  • NIH HHS
  • NINDS NIH HHS
  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Kelly, C. J., Couch, R. K., Ha, V. T., Bodart, C. M., Wu, J., Huff, S., Herrel, N. T., Kim, H. D., Zimmermann, A. O., Shattuck, J., Pan, Y. C., Kaeberlein, M., & Grillo, A. S. (2023). Iron status influences mitochondrial disease progression in Complex I-deficient mice. eLife. https://doi.org/10.7554/elife.75825

Vancouver

Kelly CJ, Couch RK, Ha VT, Bodart CM, Wu J, Huff S, et al. Iron status influences mitochondrial disease progression in Complex I-deficient mice. eLife. 2023. doi:10.7554/elife.75825

BibTeX
@article{Kelly2023,
  author = {Kelly, C J and Couch, Reid K and Ha, Vivian T and Bodart, Camille M and Wu, Judy and Huff, Sydney and Herrel, Nicole T and Kim, Hyunsung D and Zimmermann, Azaad O and Shattuck, Jessica and Pan, Yu-Chen and Kaeberlein, Matt and Grillo, Anthony S},
  title = {Iron status influences mitochondrial disease progression in Complex I-deficient mice},
  journal = {eLife},
  year = {2023},
  doi = {10.7554/elife.75825}
}
Kostenlos starten →